These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3950777)

  • 1. Optimal management of asymptomatic workers at high risk of bladder cancer.
    Schulte PA; Ringen K; Hemstreet GP
    J Occup Med; 1986 Jan; 28(1):13-7. PubMed ID: 3950777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for bladder cancer in high-risk groups: delineation of the problem.
    Schulte PA
    J Occup Med; 1990 Sep; 32(9):789-92. PubMed ID: 2074499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytologic detection of urothelial cancer and other abnormalities in a cohort of workers exposed to aromatic amines.
    Crosby JH; Allsbrook WC; Koss LG; Bales CE; Witherington R; Schulte PA; Hemstreet G; Ringer K
    Acta Cytol; 1991; 35(3):263-8. PubMed ID: 2042428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific aromatic amines as occupational bladder carcinogens.
    Clayson DB
    Natl Cancer Inst Monogr; 1981 Dec; (58):15-9. PubMed ID: 7341971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Occupational exposure and bladder cancer].
    Conso F
    Rev Prat; 2004 Oct; 54(15):1665-70. PubMed ID: 15605580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Historical and modern role of cystoscopy and bladder mucosal biopsy in detecting bladder cancer in a high-risk population.
    Prout GR
    J Occup Med; 1990 Sep; 32(9):834-7. PubMed ID: 2074506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Occupational cancer of the urinary bladder: the diagnostic value of urinary cytology in dyestuff workers exposed to aromatic amine].
    Matsushima M; Murakami N; Fukazawa K; Yagishita T; Fujio K; Miura K; Sawamura Y; Tajima M; Nakayama K; Shirai M; Ando K
    Nihon Hinyokika Gakkai Zasshi; 1983 Jan; 74(1):81-99. PubMed ID: 6865154
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative fluorescence image analysis in bladder cancer screening.
    Hemstreet GP; Hurst RE; Bass RA; Rao JY
    J Occup Med; 1990 Sep; 32(9):822-8. PubMed ID: 2074505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment of a cohort exposed to aromatic amines. Initial results.
    Schulte PA; Ringen K; Hemstreet GP; Altekruse EB; Gullen WH; Patton MG; Allsbrook WC; Crosby JH; West SS; Witherington R
    J Occup Med; 1985 Feb; 27(2):115-21. PubMed ID: 3884754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening workers exposed to suspect bladder carcinogens.
    Cartwright RA
    J Occup Med; 1986 Oct; 28(10):1017-9. PubMed ID: 3772536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aromatic amines in the work environment and urothelial tumors].
    Conso F
    Sem Hop; 1983 Sep; 59(29-30):2103-6. PubMed ID: 6312581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational risk factors for male bladder cancer: results from a population based case cohort study in the Netherlands.
    Zeegers MP; Swaen GM; Kant I; Goldbohm RA; van den Brandt PA
    Occup Environ Med; 2001 Sep; 58(9):590-6. PubMed ID: 11511746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis of primary tumors of the bladder].
    Bittard M
    J Urol (Paris); 1985; 91(6):320-400. PubMed ID: 2936829
    [No Abstract]   [Full Text] [Related]  

  • 14. [Occupational cancer of the urinary bladder: the diagnostic value of urinary cytology in dyestuff workers exposed to aromatic amines].
    Matsushima M
    Hinyokika Kiyo; 1989 Dec; 35(12):2033-40. PubMed ID: 2618902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines.
    Droller MJ
    J Urol; 1998 Aug; 160(2):618. PubMed ID: 9679939
    [No Abstract]   [Full Text] [Related]  

  • 16. The early changes in the development of bladder cancer in patients exposed to known industrial carcinogens.
    Glashan RW; Wijesinghe DP; Riley A
    Br J Urol; 1981 Dec; 53(6):571-7. PubMed ID: 7317744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notification and risk assessment for bladder cancer of a cohort exposed to aromatic amines. III. Mortality among workers exposed to aromatic amines in the last beta-naphthylamine manufacturing facility in the United States.
    Stern FB; Murthy LI; Beaumont JJ; Schulte PA; Halperin WE
    J Occup Med; 1985 Jul; 27(7):495-500. PubMed ID: 4032086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological monitoring of risk of bladder cancer in persons occupationally exposed to aromatic amines.
    Indulski JA; Lutz W
    Pol J Occup Med Environ Health; 1992; 5(2):143-51. PubMed ID: 1392660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder cancer mortality of workers exposed to aromatic amines: analysis of models of carcinogenesis.
    Decarli A; Peto J; Piolatto G; La Vecchia C
    Br J Cancer; 1985 May; 51(5):707-12. PubMed ID: 3994914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acetylation phenotype as a biomarker of sensitivity to the carcinogenic effect of aromatic amines].
    Indulski JA; Krajewska B; Lutz W
    Med Pr; 1992; 43(5):427-35. PubMed ID: 1293477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.